The Leukemia & Lymphoma Society and Valor Biotherapeutics Partner to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients

Anti-CD20-Interferon Alpha Fusion Protein is a promising therapy for NHL patients resistant to standard therapy

Researchers Funded by The Leukemia & Lymphoma Society Present Innovative Science at AACR Annual Meeting 2013

Advances in targeted therapies, immunotherapies and epigenetics among highlights

Take the Skyhook Challenge and Help Beat Blood Cancer

LLS Helps Launch Contest to Honor NBA Legend Kareem Abdul-Jabbar and Raise Awareness of Blood Cancer

News

Media Contacts

If you're a member of the media, please direct all inquiries for The Leukemia & Lymphoma Society's (LLS's) Western & Central New York Chapter to luann.burgio@lls.org or call our Chapter Office at 716.834.2578 or 800.784.2368, ext. 4663.

Thank you!